Predictors of myocardial fibrosis and response to anti-fibrotic therapy in heart failure with preserved ejection fraction
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-0743
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Predictors of myocardial fibrosis and response to anti-fibrotic therapy in heart failure with preserved ejection fraction ; day:9 ; month:2 ; year:2022 ; pages:1-10
The international journal of cardiovascular imaging ; (9.2.2022), 1-10
- Urheber
-
Lewis, Gavin A.
Rosala-Hallas, Anna
Dodd, Susanna
Schelbert, Erik B.
Williams, Simon G.
Cunnington, Colin
McDonagh, Theresa
Miller, Christopher A.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s10554-022-02544-9
- URN
-
urn:nbn:de:101:1-2022051520021618086518
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:22 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lewis, Gavin A.
- Rosala-Hallas, Anna
- Dodd, Susanna
- Schelbert, Erik B.
- Williams, Simon G.
- Cunnington, Colin
- McDonagh, Theresa
- Miller, Christopher A.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
Biomarkers in heart failure with preserved ejection fraction
Comorbidities in heart failure with preserved ejection fraction
Animal models of heart failure with preserved ejection fraction
Heart Failure with Preserved Ejection Fraction—a Concise Review
133 Obesity is associated with decreased myocardial contraction fraction despite preserved ejection fraction
Epicardial Adipose Tissue Thickness and Preserved Ejection Fraction Heart Failure
Gender-related differences in heart failure with preserved ejection fraction
Adhesive anti-fibrotic interfaces on diverse organs
Endostatin a Potential Biomarker for Heart Failure with Preserved Ejection Fraction
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment
Genetic architecture of heart failure with preserved versus reduced ejection fraction
Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
Biomarkers in heart failure with preserved ejection fraction
Comorbidities in heart failure with preserved ejection fraction
Animal models of heart failure with preserved ejection fraction
Heart Failure with Preserved Ejection Fraction—a Concise Review
133 Obesity is associated with decreased myocardial contraction fraction despite preserved ejection fraction
Epicardial Adipose Tissue Thickness and Preserved Ejection Fraction Heart Failure
Gender-related differences in heart failure with preserved ejection fraction
Adhesive anti-fibrotic interfaces on diverse organs
Endostatin a Potential Biomarker for Heart Failure with Preserved Ejection Fraction
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment
Genetic architecture of heart failure with preserved versus reduced ejection fraction
Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
Biomarkers in heart failure with preserved ejection fraction
Comorbidities in heart failure with preserved ejection fraction
Animal models of heart failure with preserved ejection fraction
Heart Failure with Preserved Ejection Fraction—a Concise Review
133 Obesity is associated with decreased myocardial contraction fraction despite preserved ejection fraction
Epicardial Adipose Tissue Thickness and Preserved Ejection Fraction Heart Failure
Gender-related differences in heart failure with preserved ejection fraction
Adhesive anti-fibrotic interfaces on diverse organs
Endostatin a Potential Biomarker for Heart Failure with Preserved Ejection Fraction
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment